5-Fluorocytosine;2-hydroxy-4-amino-5-fluoropyrimidine;4-AMINO-5-FLUORO-2(1H)-PYRIMIDINE;4-amino-5-fluoro-2(1h)-pyrimidinone;4-AMINO-5-FLUORO-2-HYDROXYPYRIMIDINE;4-AMINO-5-FLUORO-3H-PYRIMIDIN-2-ONE;5-FC;5-FLUCYTOSINE;ALCOBON;ancobon;ancotil;FLUCYSTINE;FLUCYTOSIN;FLUCYTOSINE;TIMTEC-BB SBB000061;4-amino-5-fluoro-2(1h)-pyrimidinon;4-Amino-5-fluoro-2(1H)-pyrmidinone;5-fluorocystosine;5-fluorocytosin;Fluorocytosine;6-AMINO-5-FLUORO-1,2-DIHYDROPYRIMIDIN-2-ONE;6-amino-5-fluoro-1H-pyrimidin-2-one;5-FC,RO 2-9915;Fluocytosine;Fluorcytosine;NSC 103805;Ro 2-9915;4-Amino-5-fluoropyrimidin-2(1H)-one;Flucytosinum;Cytosine, 5-fluoro-;Flucitosina;5-Flurocytosine;2(1H)-Pyrimidinone, 4-amino-5-fluoro-;5-fluoro cytosine;Flucitosina [DCIT];Ro 29915 E/265601;Flucytosinum [INN-Latin];Ancobon (TN);Flucytosine (;4-Amino-5-fluoro-2-pyrimidone;Flucytosine;Flucytosine 100 microg/mL in Acetonitrile:Water;NS00000532;SR-01000721885;HMS3393M04;AC-11748;Ro-2-9915;CCG-213434;SMR000059047;FLUCYTOSINE (MART.);HSDB 3082;HMS2097L10;FLUCYTOSINE [MI];BPBio1_000956;FLUCYTOSINE [ORANGE BOOK];NSC-103805;Flucytosine (USAN:USP:INN:BAN:JAN);CHEBI:5100;4-amino-5-fluoropyrimidin-2-ol;130256-61-0;Flucytosone;BDBM50248003;6-amino-5-fluoro-3-hydropyrimidin-2-one;1LD;WLN: T6MVNJ DZ EF;AKOS004912683;SCHEMBL24063;FLUCYTOSINE [INN];Prestwick0_000934;2(1H)-Pyrimidinone, 4-amino-5-fluoro-);D00323;5-Fluorocytosine, Antibiotic for Culture Media Use Only;MFCD00006035;CAS-2022-85-7;Flucytosine,(S);NC00087;BSPBio_000868;HMS3655G17;AM20090149;6-amino-5-fluoropyrimidin-2(1H)-one;6-Amino-2-oxo-5-fluoropyrimidine;4-AMINO-2-HYDROXY-5-FLUOROPYRIMIDINE;2-pyrimidinol,4-amino-5-fluoro-;5-Fluorocytosine, Vetec(TM) reagent grade, 99%;FLUCYTOSINE [EP MONOGRAPH];EMTRICITABINE IMPURITY E;HMS1570L10;FT-0601273;Flucytosine (Ancobon);Flucytosinum (INN-Latin);AB00444223-16;SPBio_003037;Flucytosine, United States Pharmacopeia (USP) Reference Standard;SB57097;MLS000069463;4-amino-5-fluoro-1,2-dihydropyrimidin-2-one;HMS2093J05;4-Amino-5-fluoro-2-hyroxypyrimidine;Opera_ID_178;s1666;flucytosina;BP-30254;SY004438;5-fluorocytosine Form I;FLUCYTOSINE [WHO-IP];HY-B0139;HMS2051M04;SW197278-3;FLUCYTOSINE (EP MONOGRAPH);NCGC00016599-05;2(1H)-Pyrimidinone, 6-amino-5-fluoro-;FLUCYTOSINE [JAN];BCP9000692;A814346;FLUCYTOSINE [USP MONOGRAPH];4-Amino-5-fluoro-1H-pyrimidin-2-one;EN300-117264;Flucytosine [USAN:USP:INN:BAN:JAN];FLUCYTOSINE (USP IMPURITY);MLS000759519;CS-1935;UNII-D83282DT06;5-fluoro-cytosine;BCP0726000281;Flucytosine, European Pharmacopoeia (EP) Reference Standard;4-AMINO-5-FLUOROPYRIMIDIN-2(1H)-ONE [WHO-IP];EMTRICITABINE IMPURITY E [WHO-IP];Flucytosine, Pharmaceutical Secondary Standard; Certified Reference Material;KS-1060;MLS001424013;Flucytosine, 5-Fluorocytosine;FLUCYTOSINE [MART.];NSC-759130;117969-88-7;FLUCYTOSINE [USP IMPURITY];Q238490;NSC103805;FLUCYTOSINE (USP MONOGRAPH);Flucytosine 2.0 mg/ml in Metha...